Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

Bristol Myers Squibb logo

BMS and Celgene to research cancer immunotherapy combo

Companies will study combination of nivolumab and Abraxane

Allergan appoints financial head

Jim Hindman named chief financial officer

- PMLiVE

Sue Ryder appoints head of PR, celebrity and communications

Susan Fiddian joins charity focused on hospice and end-of-life care needs

- PMLiVE

Brilinta bill of health boosts AstraZeneca

US drops investigation into study data

Novartis building

Novartis licenses tuberculosis R&D to TB Alliance

Includes drugs to tackle resistant forms of the disease

- PMLiVE

UDG sells stake in UniDrug

Alliance Boots will take over full control of supply chain specialist

- PMLiVE

Catalent appoints two board members

Jack Stahl and Rolf Classon to advise drug development, delivery and supply company

- PMLiVE

History rhymes: modern globalisation trends mirror the past

Recent events are an echo of the late 19th century

- PMLiVE

NICE backs Celgene’s Revlimid in bone marrow disorder

Recommends that drug can be used on NHS to treat myelodysplastic syndromes

- PMLiVE

‘Tentative’ US approval for Lilly/Boehringer’s Lantus copy

Full FDA recommendation for insulin is dependent on lawsuit filed by Sanofi

- PMLiVE

Chugai soars on Roche buyout rumours

Reports circulating that Swiss company is poised to make $10bn offer

- PMLiVE

Eisai ‘outraged’ by IQWIG’s failure to back epilepsy drug

German cost-effectiveness body once again says Fycompa should not be reimbursed

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links